Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to collect data to ascertain the Positive Predictive Value (PPV) and Negative Predictive Value (NPV) of the current version of the Cognoa diagnostic device.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cognoa, Inc.
NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT06158581 · Autism Spectrum Disorder
NCT07524192 · Autism Spectrum Disorder, Developmental Disabilities, and more
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
Melmed Center
Scottsdale, Arizona
The Nicholls Group
Scottsdale, Arizona
Orange County Child Neurology
Laguna Niguel, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions